Results

Total Results: 2,207 records

Showing results for "drug".

101. Antipsychotics for the Prevention and Treatment of Delirium: A Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/antipsychotics/research-protocol
     January 01, 2019 - Currently, there are no medications approved by the Food and Drug Administration for the prevention and … Comparators: KQ 1: Non-drug approaches to preventing delirium, placebo, active control, usual care KQ … For KQ 2, we will include non-drug approaches to treating delirium, including placebo, active control … Non-drug interventions will be categorized following the scheme developed by Oh and colleagues. 19 All … Does antipsychotic drug use increase the risk of long term mortality?

102. Data Points #6: Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009 | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/cancer-drugs-utilization-cost/research
     December 01, 2019 - 10 Medicare fee-for-service (FFS) payments (excluding Part C advantage plans and Part D prescription drug … Drugs used in the treatment of cancer account for a large share of Medicare Part B drug expenditures. … In 2008, five of the six medications accounting for the largest proportion of Part B drug expenditures … costs to prescription drug plans. … Although the Food and Drug Administration (FDA) has labeled peginterferon alfa-2a for use in hepatitis

103. Rheumatoid Arthritis | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/rheumatoid-arthritis
     July 16, 2018 - rheumatoidarthritis.html Products Systematic Review Archived July 16, 2018 Drug … Early Rheumatoid Arthritis: A Systematic Review Update Research Protocol May 24, 2017 Drug … 2006-2009 Research Protocol Archived December 6, 2010 Comparative Effectiveness of Drug … Report Research Protocol Archived December 6, 2010 Comparative Effectiveness of Drug … Arthritis Systematic Review Archived November 19, 2007 Comparative Effectiveness of Drug

104. DEcIDE 32: The Incident User Design in Comparative Effectiveness Research (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
     May 01, 2012 - therapy and ignoring the duration of drug use. … For example, some propensity scores predict a combination of incident drug use, persistence with a drug … newly marketed drug. … or class be compared with incident users of another drug or class? … Pharmacoepidemiol Drug Safety 2007;16:329-36. 4. Ray WA.

105. Making Healthcare Safer IV: Final Report on Prioritization of Patient Safety Practices for a New Rapid Review or Rapid Response | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/prioritization-patient-safety-practices
     January 01, 2024 - List of PSPs that were merged into one of the PSPs in our revised framework Category Item Adverse Drug … Drug Events: Harms due to Anticoagulants Single Provider Adverse Drug Events: Infusion Pumps/Medication … Error Staff Education and Training Structured Process Changes/Workflow Redesign Adverse Drug Events: … Reducing Adverse Drug Events in Older Adults Use of Screening Tool of Older People's Prescriptions ( … | Sep 7, 2023 Making Healthcare Safer IV: Prevention of Transmission of Infection With Multi-Drug

106. Comparative Effectiveness Review No. 262_Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-summary.pdf
     November 01, 2023 - Our concluding assessment of this drug remains the same as the prior 2014 review. … We reviewed studies for three medications with Food and Drug Administration approval for alcohol use … As before, we included all medications with Food and Drug Administration indications for alcohol use … https://effectivehealthcare.ahrq.gov/products /alcohol-misuse-drug-therapy/research 2. … Drug and placebo responses in chronic alcoholics. Psychiatric Research Reports. 1968 Mar;24:44-60.

107. Autoimmune Diseases | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/autoimmune-diseases
     November 01, 2024 - Other Immunosuppressants: A Rapid Response Review Research Protocol May 24, 2017 Drug … Glucose Monitoring: Comparative Effectiveness Systematic Review Archived June 1, 2012 Drug … Rheumatoid Arthritis in Adults: An Update Systematic Review Archived June 1, 2012 Drug … Mellitus Research Protocol Archived December 6, 2010 Comparative Effectiveness of Drug … Report Research Protocol Archived December 6, 2010 Comparative Effectiveness of Drug

108. Autoimmune Diseases | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/autoimmune-diseases?page=0
     November 01, 2024 - Other Immunosuppressants: A Rapid Response Review Research Protocol May 24, 2017 Drug … Glucose Monitoring: Comparative Effectiveness Systematic Review Archived June 1, 2012 Drug … Rheumatoid Arthritis in Adults: An Update Systematic Review Archived June 1, 2012 Drug … Mellitus Research Protocol Archived December 6, 2010 Comparative Effectiveness of Drug … Report Research Protocol Archived December 6, 2010 Comparative Effectiveness of Drug

109. Arthritis | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/arthritis
     November 14, 2023 - 2022 Cervical Degenerative Disease Treatment Research Protocol May 24, 2017 Drug … for Knee Pain Secondary to Osteoarthritis Systematic Review Archived June 1, 2012 Drug … Arthritis in Adults: Update of a 2007 Report Systematic Review Archived June 1, 2012 Drug … Osteoarthritis Research Protocol Archived December 6, 2010 Comparative Effectiveness of Drug … Report Research Protocol Archived December 6, 2010 Comparative Effectiveness of Drug

110. Arthritis | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/arthritis?page=0
     November 14, 2023 - 2022 Cervical Degenerative Disease Treatment Research Protocol May 24, 2017 Drug … for Knee Pain Secondary to Osteoarthritis Systematic Review Archived June 1, 2012 Drug … Arthritis in Adults: Update of a 2007 Report Systematic Review Archived June 1, 2012 Drug … Osteoarthritis Research Protocol Archived December 6, 2010 Comparative Effectiveness of Drug … Report Research Protocol Archived December 6, 2010 Comparative Effectiveness of Drug

111. Evidence-based Practice Center Systematic Review Protocol: Therapies for Clinically Localized Prostate Cancer (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
     November 02, 2019 - [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer … [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer … [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer … [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer … [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer

112. Therapies for Clinically Localized Prostate Cancer | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies/protocol
     March 01, 2020 - [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer … [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer … [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer … [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer … [mp=title, abstract, heading word, drug trade name, original title, device manufacturer, drug manufacturer

113. Evaluation of Effectiveness and Safety of Antiepileptic Medications in Patients With Epilepsy (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_research-protocol.pdf
     February 01, 2008 - drug, each newer antiepileptic drug will be compared individually against the older antiepileptic drug … innovator antiepileptic drug group, each generic antiepileptic drug will be compared individually against … the innovator antiepileptic drug (as a separate trial) by dividing the innovator antiepileptic drug … A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product … Condition- specific drug substitution legislation: epilepsy.

114. FRN 35 - Preventive Pharmacological Treatments for Migraine in Adults: Future Research Needs (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/migraine-future_research.pdf
     April 01, 2013 - Are drug side effects lessened when two drugs are used at lower dosages instead of one drug at a higher … , patient education, drug surveillance, or interactive drug monitoring) influence results? … , patient education, drug surveillance, or interactive drug monitoring) influence results? … Are drug side effects lessened when two drugs are used at lower dosages instead of one drug at a higher … What is the appropriate timing to evaluate treatment success or failure for each drug/class of drug for

115. Obesity (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - The drug has been classified by the U.S. … Drug Enforcement Administration as a Schedule IV drug; it became available for prescribing in June … Drug Enforcement Administration (DEA) as a Schedule IV drug (i.e., with a low potential for abuse and … The drug also decreases glucose levels. … Food and Drug Administration (FDA)).

116. Evidence Report on the (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/osteoarthritis-pain_research-protocol.pdf
     August 05, 2010 - that standard dosing as labeled or alternative dosage strategies, such as intermittent dosing and drug … Oral drugs (trade names provided only for drugs under patent) Drug (any trade name): acetaminophen … systemic lupus erythematosus; rheumatoid arthritis; stable angina, chronic; unstable angina Drug … impairment: reduce dose by 50%; elderly patients weighing < 50 kg: initiate at lowest dose Drug … /day Renal impairment and elderly: initiate with lowest dose possible, then monitor closely Drug

117. Migraine in Adults: Preventive Pharmacologic Treatments | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/migraine-prevention/research-2013
     December 01, 2019 - For episodic migraine, RCTs examined 59 drugs from 14 drug classes. … Individual RCTs of drug-management interventions for episodic migraine offered low-strength evidence … Future research should examine the role of patient characteristics on drug benefits and safety.

118. Over-the-Counter Medicines | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/over-counter-medicines
     December 21, 2010 - In the United States, the Food and Drug Administration decides whether a medicine is safe enough to … Food and Drug Administration Source https://medlineplus.gov/overthecountermedicines.html

119. Clinical Effectiveness of Coronary Stents in the Elderly: Results From 262,700 Patients in the American College of Cardiology-National Cardiovascular Data Registry | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/coronary-stents-outcomes/research
     January 01, 2020 - United States Food and Drug Administration. FDA Statement on coronary drug-eluting stents. … United States Food and Drug Administration. … Update to FDA statement on coronary drug-eluting stents. … Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents. … An Observational Study of Drug-Eluting Versus Bare-Metal Stents.

120. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1506.pdf
     December 01, 2015 - Two third- party payers consider Sovaldi a preferred drug; eight consider Harvoni a preferred drug. … Daklinza is an investigational HCV NS5A inhibitor.15 The drug purportedly has a low drug-drug interaction … Gilead gets U.S. approval to sell new hepatitis C drug: drug is seen building on the highly successful … Sovaldi and reigniting debate about drug prices. … Nat Rev Drug Discov. 2013 Jun;12(6):409-11.